Pricing Log in Create free account

Gelteq Limited (GELS) vs cbdMD, Inc. (YCBD)

Gelteq Limited and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited is the larger, with a market value of $4.9M against $4.4M — 1.1× the size. Across the 9 metrics below, Gelteq Limited leads on 6 and cbdMD, Inc. on 3.

Valuation

Metric GELS YCBD Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — 0.19 2.08
P/B n/m 0.49 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 0.21 2.87
Earnings yield — (80.50%) (15.94%)
Free cash flow yield 0.00% (61.46%) 0.00%

Profitability

Metric GELS YCBD Drug Manufacturers Specialty & Generic median
Gross margin — 57.68% 53.51%
Operating margin — (13.87%) 0.00%
Net margin — (14.71%) (2.45%)
Free cash flow margin 0.00% (11.51%) 0.00%
Return on equity 0.00% (43.01%) (0.80%)
Return on assets 0.00% (26.73%) (1.67%)
Return on invested capital 0.00% (29.78%) 0.00%

Growth

Metric GELS YCBD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 10.01% 5.22%
EPS growth (last fiscal year) (62.07%) 92.39% 42.91%
Revenue growth, 5-year CAGR — (14.45%) 7.24%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS YCBD Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.04
Current ratio 0.09 2.50 2.41
Net debt to EBITDA (0.91) 6.17 1.01

Dividend

Metric GELS YCBD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric GELS YCBD Drug Manufacturers Specialty & Generic median
Market cap 4.88m 4.35m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack